Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 106 entries
Sorted by: Best Match Show Resources per page
A palladium-catalyzed C-H functionalization route to ketones .

Chemical science

Levesque TM, Kinney RG, Arndtsen BA.
PMID: 34122815
Chem Sci. 2020 Feb 20;11(11):3104-3109. doi: 10.1039/d0sc00085j.

We describe the development of a new palladium-catalyzed method to generate ketones

Cite
Levesque TM, Kinney RG, Arndtsen BA. A palladium-catalyzed C-H functionalization route to ketones . Chem Sci. 2020;11(11):3104-3109doi: 10.1039/d0sc00085j.
Levesque, T. M., Kinney, R. G., & Arndtsen, B. A. (2020). A palladium-catalyzed C-H functionalization route to ketones . Chemical science, 11(11), 3104-3109. https://doi.org/10.1039/d0sc00085j
Levesque, Taleah M, et al. "A palladium-catalyzed C-H functionalization route to ketones ." Chemical science vol. 11,11 (2020): 3104-3109. doi: https://doi.org/10.1039/d0sc00085j
Levesque TM, Kinney RG, Arndtsen BA. A palladium-catalyzed C-H functionalization route to ketones . Chem Sci. 2020 Feb 20;11(11):3104-3109. doi: 10.1039/d0sc00085j. PMID: 34122815; PMCID: PMC8157493.
Copy Download .nbib Format: NLM
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.

Frontiers in neurology

Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A.
PMID: 34659081
Front Neurol. 2021 Oct 01;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021.

No abstract available.

Cite
Pagano G, Boess FG, Taylor KI, et al. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Front Neurol. 2021;12:705407doi: 10.3389/fneur.2021.705407.
Pagano, G., Boess, F. G., Taylor, K. I., Ricci, B., Mollenhauer, B., Poewe, W., Boulay, A., Anzures-Cabrera, J., Vogt, A., Marchesi, M., Post, A., Nikolcheva, T., Kinney, G. G., Zago, W. M., Ness, D. K., Svoboda, H., Britschgi, M., Ostrowitzki, S., Simuni, T., Marek, K., Koller, M., Sevigny, J., Doody, R., Fontoura, P., Umbricht, D., Bonni, A. (2021). A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Frontiers in neurology, 12705407. https://doi.org/10.3389/fneur.2021.705407
Pagano, Gennaro, et al. "A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data." Frontiers in neurology vol. 12 (2021): 705407. doi: https://doi.org/10.3389/fneur.2021.705407
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Front Neurol. 2021 Oct 01;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. PMID: 34659081; PMCID: PMC8518716.
Copy Download .nbib Format: NLM
Repair of a Syphilitic Aneurysm of the Noncoronary Sinus.

Aorta (Stamford, Conn.)

Kinsey DJ, Zambrano C, Suarez-Pierre A, Kumar A, Isenbergh E, Lawton JS, Siegenthaler MP.
PMID: 33152789
Aorta (Stamford). 2020 Jun;8(3):80-82. doi: 10.1055/s-0040-1714057. Epub 2020 Nov 05.

About one-tenth of patients with untreated chronic syphilis and tertiary syphilis develop structural complications involving the coronary ostia, ascending aorta, or aortic root. We describe a unique case of a large aortic root aneurysm of the noncoronary sinus with...

Cite
Kinsey DJ, Zambrano C, Suarez-Pierre A, et al. Repair of a Syphilitic Aneurysm of the Noncoronary Sinus. Aorta (Stamford). 2020;8(3):80-82doi: 10.1055/s-0040-1714057.
Kinsey, D. J., Zambrano, C., Suarez-Pierre, A., Kumar, A., Isenbergh, E., Lawton, J. S., & Siegenthaler, M. P. (2020). Repair of a Syphilitic Aneurysm of the Noncoronary Sinus. Aorta (Stamford, Conn.), 8(3), 80-82. https://doi.org/10.1055/s-0040-1714057
Kinsey, Danielle J, et al. "Repair of a Syphilitic Aneurysm of the Noncoronary Sinus." Aorta (Stamford, Conn.) vol. 8,3 (2020): 80-82. doi: https://doi.org/10.1055/s-0040-1714057
Kinsey DJ, Zambrano C, Suarez-Pierre A, Kumar A, Isenbergh E, Lawton JS, Siegenthaler MP. Repair of a Syphilitic Aneurysm of the Noncoronary Sinus. Aorta (Stamford). 2020 Jun;8(3):80-82. doi: 10.1055/s-0040-1714057. Epub 2020 Nov 05. PMID: 33152789; PMCID: PMC7644290.
Copy Download .nbib Format: NLM
Interrater Reliability in the American Board of Physical Medicine and Rehabilitation Part II Certification Examination: Impact of a New Assessment Design.

American journal of physical medicine & rehabilitation

Kinney CL, Raddatz MM, Robinson LR, Garrison CJ, Sabharwal S.
PMID: 34347627
Am J Phys Med Rehabil. 2021 Aug 03; doi: 10.1097/PHM.0000000000001859. Epub 2021 Aug 03.

OBJECTIVE: The design of medical board certification examinations continues to evolve with advances in testing innovations and psychometric analysis. The potential for subjectivity is inherent in the design of oral board examinations, making improvements in reliability and validity especially...

Cite
Kinney CL, Raddatz MM, Robinson LR, et al. Interrater Reliability in the American Board of Physical Medicine and Rehabilitation Part II Certification Examination: Impact of a New Assessment Design. Am J Phys Med Rehabil. 2021;doi: 10.1097/PHM.0000000000001859.
Kinney, C. L., Raddatz, M. M., Robinson, L. R., Garrison, C. J., & Sabharwal, S. (2021). Interrater Reliability in the American Board of Physical Medicine and Rehabilitation Part II Certification Examination: Impact of a New Assessment Design. American journal of physical medicine & rehabilitation, . https://doi.org/10.1097/PHM.0000000000001859
Kinney, Carolyn L, et al. "Interrater Reliability in the American Board of Physical Medicine and Rehabilitation Part II Certification Examination: Impact of a New Assessment Design." American journal of physical medicine & rehabilitation vol. (2021). doi: https://doi.org/10.1097/PHM.0000000000001859
Kinney CL, Raddatz MM, Robinson LR, Garrison CJ, Sabharwal S. Interrater Reliability in the American Board of Physical Medicine and Rehabilitation Part II Certification Examination: Impact of a New Assessment Design. Am J Phys Med Rehabil. 2021 Aug 03; doi: 10.1097/PHM.0000000000001859. Epub 2021 Aug 03. PMID: 34347627.
Copy Download .nbib Format: NLM
Air Trapping versus Atelectasis in Obesity: Relationship to Late-onset Non-allergic Asthma and Aging.

Annals of the American Thoracic Society

Bhatawadekar SA, Peters U, Walsh RR, Daphtary N, MacLean ES, Hodgdon K, Kinsey CM, Kaminsky DA, Bates JHT, Dixon AE.
PMID: 34343031
Ann Am Thorac Soc. 2021 Aug 03; doi: 10.1513/AnnalsATS.202010-1317RL. Epub 2021 Aug 03.

No abstract available.

Cite
Bhatawadekar SA, Peters U, Walsh RR, et al. Air Trapping versus Atelectasis in Obesity: Relationship to Late-onset Non-allergic Asthma and Aging. Ann Am Thorac Soc. 2021;doi: 10.1513/AnnalsATS.202010-1317RL.
Bhatawadekar, S. A., Peters, U., Walsh, R. R., Daphtary, N., MacLean, E. S., Hodgdon, K., Kinsey, C. M., Kaminsky, D. A., Bates, J. H. T., & Dixon, A. E. (2021). Air Trapping versus Atelectasis in Obesity: Relationship to Late-onset Non-allergic Asthma and Aging. Annals of the American Thoracic Society, . https://doi.org/10.1513/AnnalsATS.202010-1317RL
Bhatawadekar, Swati A, et al. "Air Trapping versus Atelectasis in Obesity: Relationship to Late-onset Non-allergic Asthma and Aging." Annals of the American Thoracic Society vol. (2021). doi: https://doi.org/10.1513/AnnalsATS.202010-1317RL
Bhatawadekar SA, Peters U, Walsh RR, Daphtary N, MacLean ES, Hodgdon K, Kinsey CM, Kaminsky DA, Bates JHT, Dixon AE. Air Trapping versus Atelectasis in Obesity: Relationship to Late-onset Non-allergic Asthma and Aging. Ann Am Thorac Soc. 2021 Aug 03; doi: 10.1513/AnnalsATS.202010-1317RL. Epub 2021 Aug 03. PMID: 34343031.
Copy Download .nbib Format: NLM
The annual report.

Hospital management

KINSEY JR.
PMID: 12999211
Hosp Manage. 1952 Nov;74(5):44.

No abstract available.

Cite
KINSEY JR. The annual report. Hosp Manage. 1952;74(5):44
KINSEY, J. R. (1952). The annual report. Hospital management, 74(5), 44.
KINSEY, J R. "The annual report." Hospital management vol. 74,5 (1952): 44.
KINSEY JR. The annual report. Hosp Manage. 1952 Nov;74(5):44. PMID: 12999211.
Copy Download .nbib Format: NLM
Novel binaphthyl and biphenyl α- and β-amino acids and esters: organocatalysis of asymmetric Diels-Alder reactions. A combined synthetic and computational study.

Organic & biomolecular chemistry

Bulman Page PC, Kinsey FS, Chan Y, Strutt IR, Slawin AMZ, Jones GA.
PMID: 30259945
Org Biomol Chem. 2018 Oct 17;16(40):7400-7416. doi: 10.1039/c8ob01795f.

Asymmetric catalysis of the Diels-Alder reaction between cyclopentadiene and cinnamaldehydes has been studied using as catalysts a range of novel α- and β-aminoacids and aminoesters with binaphthyl and biphenyl backbones, providing enantioselectivities of up to 62% ee. B3LYP/6-31G* calculations,...

Cite
Bulman Page PC, Kinsey FS, Chan Y, et al. Novel binaphthyl and biphenyl α- and β-amino acids and esters: organocatalysis of asymmetric Diels-Alder reactions. A combined synthetic and computational study. Org Biomol Chem. 2018;16(40):7400-7416doi: 10.1039/c8ob01795f.
Bulman Page, P. C., Kinsey, F. S., Chan, Y., Strutt, I. R., Slawin, A. M. Z., & Jones, G. A. (2018). Novel binaphthyl and biphenyl α- and β-amino acids and esters: organocatalysis of asymmetric Diels-Alder reactions. A combined synthetic and computational study. Organic & biomolecular chemistry, 16(40), 7400-7416. https://doi.org/10.1039/c8ob01795f
Bulman Page, Philip C, et al. "Novel binaphthyl and biphenyl α- and β-amino acids and esters: organocatalysis of asymmetric Diels-Alder reactions. A combined synthetic and computational study." Organic & biomolecular chemistry vol. 16,40 (2018): 7400-7416. doi: https://doi.org/10.1039/c8ob01795f
Bulman Page PC, Kinsey FS, Chan Y, Strutt IR, Slawin AMZ, Jones GA. Novel binaphthyl and biphenyl α- and β-amino acids and esters: organocatalysis of asymmetric Diels-Alder reactions. A combined synthetic and computational study. Org Biomol Chem. 2018 Oct 17;16(40):7400-7416. doi: 10.1039/c8ob01795f. PMID: 30259945.
Copy Download .nbib Format: NLM
Impact of Biofuel Blends on Black Carbon Emissions from a Gas Turbine Engine.

Energy & fuels : an American Chemical Society journal

Kumal RR, Liu J, Gharpure A, Wal RLV, Kinsey JS, Giannelli B, Stevens J, Leggett C, Howard R, Forde M, Zelenyuk-Imre A, Suski K, Payne G, Manin J, Bachalo W, Frazee R, Onasch TB, Freedman A, Kittelson DB, Swanson JJ.
PMID: 32327881
Energy Fuels. 2020 Apr 16;34(4):4958-4966. doi: 10.1021/acs.energyfuels.0c00094.

Presented here is an overview of non-volatile particulate matter (nvPM) emissions, i.e. "soot" as assessed by TEM analyses of samples collected after the exhaust of a J-85 turbojet fueled with Jet-A as well as with blends of Jet-A and...

Cite
Kumal RR, Liu J, Gharpure A, et al. Impact of Biofuel Blends on Black Carbon Emissions from a Gas Turbine Engine. Energy Fuels. 2020;34(4):4958-4966doi: 10.1021/acs.energyfuels.0c00094.
Kumal, R. R., Liu, J., Gharpure, A., Wal, R. L. V., Kinsey, J. S., Giannelli, B., Stevens, J., Leggett, C., Howard, R., Forde, M., Zelenyuk-Imre, A., Suski, K., Payne, G., Manin, J., Bachalo, W., Frazee, R., Onasch, T. B., Freedman, A., Kittelson, D. B., & Swanson, J. J. (2020). Impact of Biofuel Blends on Black Carbon Emissions from a Gas Turbine Engine. Energy & fuels : an American Chemical Society journal, 34(4), 4958-4966. https://doi.org/10.1021/acs.energyfuels.0c00094
Kumal, Raju R, et al. "Impact of Biofuel Blends on Black Carbon Emissions from a Gas Turbine Engine." Energy & fuels : an American Chemical Society journal vol. 34,4 (2020): 4958-4966. doi: https://doi.org/10.1021/acs.energyfuels.0c00094
Kumal RR, Liu J, Gharpure A, Wal RLV, Kinsey JS, Giannelli B, Stevens J, Leggett C, Howard R, Forde M, Zelenyuk-Imre A, Suski K, Payne G, Manin J, Bachalo W, Frazee R, Onasch TB, Freedman A, Kittelson DB, Swanson JJ. Impact of Biofuel Blends on Black Carbon Emissions from a Gas Turbine Engine. Energy Fuels. 2020 Apr 16;34(4):4958-4966. doi: 10.1021/acs.energyfuels.0c00094. PMID: 32327881; PMCID: PMC7180060.
Copy Download .nbib Format: NLM
New paradigm for suppression of gyrokinetic turbulence by velocity shear.

Physical review letters

Staebler GM, Waltz RE, Candy J, Kinsey JE.
PMID: 23414026
Phys Rev Lett. 2013 Feb 01;110(5):055003. doi: 10.1103/PhysRevLett.110.055003. Epub 2013 Jan 30.

The shear in the mean field velocity Doppler shift is shown to suppress the amplitude of electric potential fluctuations by inducing a shift in the peak of the radial wave number spectrum. An analytic model of the process shows...

Cite
Staebler GM, Waltz RE, Candy J, et al. New paradigm for suppression of gyrokinetic turbulence by velocity shear. Phys Rev Lett. 2013;110(5):055003doi: 10.1103/PhysRevLett.110.055003.
Staebler, G. M., Waltz, R. E., Candy, J., & Kinsey, J. E. (2013). New paradigm for suppression of gyrokinetic turbulence by velocity shear. Physical review letters, 110(5), 055003. https://doi.org/10.1103/PhysRevLett.110.055003
Staebler, G M, et al. "New paradigm for suppression of gyrokinetic turbulence by velocity shear." Physical review letters vol. 110,5 (2013): 055003. doi: https://doi.org/10.1103/PhysRevLett.110.055003
Staebler GM, Waltz RE, Candy J, Kinsey JE. New paradigm for suppression of gyrokinetic turbulence by velocity shear. Phys Rev Lett. 2013 Feb 01;110(5):055003. doi: 10.1103/PhysRevLett.110.055003. Epub 2013 Jan 30. PMID: 23414026.
Copy Download .nbib Format: NLM
The effects of a multi-ingredient dietary supplement on body composition, adipokines, blood lipids, and metabolic health in overweight and obese men and women: a randomized controlled trial.

Journal of the International Society of Sports Nutrition

Ormsbee MJ, Rawal SR, Baur DA, Kinsey AW, Elam ML, Spicer MT, Fischer NT, Madzima TA, Thomas DD.
PMID: 25093015
J Int Soc Sports Nutr. 2014 Jul 26;11:37. doi: 10.1186/1550-2783-11-37. eCollection 2014.

BACKGROUND: The present study investigated the effects of a multi-ingredient dietary supplement (MIDS) containing caffeine, conjugated linoleic acid (CLA), green tea, and branched-chain amino acids (BCAA) taken for 8 weeks on body composition, blood lipid profile, glucose, insulin, adiponectin,...

Cite
Ormsbee MJ, Rawal SR, Baur DA, et al. The effects of a multi-ingredient dietary supplement on body composition, adipokines, blood lipids, and metabolic health in overweight and obese men and women: a randomized controlled trial. J Int Soc Sports Nutr. 2014;11:37doi: 10.1186/1550-2783-11-37.
Ormsbee, M. J., Rawal, S. R., Baur, D. A., Kinsey, A. W., Elam, M. L., Spicer, M. T., Fischer, N. T., Madzima, T. A., & Thomas, D. D. (2014). The effects of a multi-ingredient dietary supplement on body composition, adipokines, blood lipids, and metabolic health in overweight and obese men and women: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 1137. https://doi.org/10.1186/1550-2783-11-37
Ormsbee, Michael J, et al. "The effects of a multi-ingredient dietary supplement on body composition, adipokines, blood lipids, and metabolic health in overweight and obese men and women: a randomized controlled trial." Journal of the International Society of Sports Nutrition vol. 11 (2014): 37. doi: https://doi.org/10.1186/1550-2783-11-37
Ormsbee MJ, Rawal SR, Baur DA, Kinsey AW, Elam ML, Spicer MT, Fischer NT, Madzima TA, Thomas DD. The effects of a multi-ingredient dietary supplement on body composition, adipokines, blood lipids, and metabolic health in overweight and obese men and women: a randomized controlled trial. J Int Soc Sports Nutr. 2014 Jul 26;11:37. doi: 10.1186/1550-2783-11-37. eCollection 2014. PMID: 25093015; PMCID: PMC4120730.
Copy Download .nbib Format: NLM
John Maxwell MacDougall; 1910-1950.

Diseases of the chest

KINSEY HI.
PMID: 14872759
Dis Chest. 1951 Oct;20(4):450.

No abstract available.

Cite
KINSEY HI. John Maxwell MacDougall; 1910-1950. Dis Chest. 1951;20(4):450
KINSEY, H. I. (1951). John Maxwell MacDougall; 1910-1950. Diseases of the chest, 20(4), 450.
KINSEY, H I. "John Maxwell MacDougall; 1910-1950." Diseases of the chest vol. 20,4 (1951): 450.
KINSEY HI. John Maxwell MacDougall; 1910-1950. Dis Chest. 1951 Oct;20(4):450. PMID: 14872759.
Copy Download .nbib Format: NLM
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma.

Proteomics. Clinical applications

Cutler P, Akuffo EL, Bodnar WM, Briggs DM, Davis JB, Debouck CM, Fox SM, Gibson RA, Gormley DA, Holbrook JD, Hunter AJ, Kinsey EE, Prinjha R, Richardson JC, Roses AD, Smith MA, Tsokanas N, Willé DR, Wu W, Yates JW, Gloger IS.
PMID: 21136851
Proteomics Clin Appl. 2008 Apr;2(4):467-77. doi: 10.1002/prca.200780101. Epub 2008 Mar 07.

Emerging disease modifying therapeutic strategies for Alzheimer's disease (AD) have generated a critical need for biomarkers of early stage disease. Here, we describe the identification and assessment of a number of candidate biomarkers in patients with mild to moderate...

Cite
Cutler P, Akuffo EL, Bodnar WM, et al. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma. Proteomics Clin Appl. 2008;2(4):467-77doi: 10.1002/prca.200780101.
Cutler, P., Akuffo, E. L., Bodnar, W. M., Briggs, D. M., Davis, J. B., Debouck, C. M., Fox, S. M., Gibson, R. A., Gormley, D. A., Holbrook, J. D., Hunter, A. J., Kinsey, E. E., Prinjha, R., Richardson, J. C., Roses, A. D., Smith, M. A., Tsokanas, N., Willé, D. R., Wu, W., Yates, J. W., & Gloger, I. S. (2008). Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma. Proteomics. Clinical applications, 2(4), 467-77. https://doi.org/10.1002/prca.200780101
Cutler, Paul, et al. "Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma." Proteomics. Clinical applications vol. 2,4 (2008): 467-77. doi: https://doi.org/10.1002/prca.200780101
Cutler P, Akuffo EL, Bodnar WM, Briggs DM, Davis JB, Debouck CM, Fox SM, Gibson RA, Gormley DA, Holbrook JD, Hunter AJ, Kinsey EE, Prinjha R, Richardson JC, Roses AD, Smith MA, Tsokanas N, Willé DR, Wu W, Yates JW, Gloger IS. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma. Proteomics Clin Appl. 2008 Apr;2(4):467-77. doi: 10.1002/prca.200780101. Epub 2008 Mar 07. PMID: 21136851.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 106 entries